Blog
About

1
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Factors associated with appropriate inhaler use in patients with COPD – lessons from the REAL survey [Erratum]

      International Journal of Chronic Obstructive Pulmonary Disease

      Dove Medical Press

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Price D, Keininger DL, Viswanad B, et al. Int J Chron Obstruct Pulmon Dis. 2018;13:695–702. The author has advised that several changes need to be made to the paper. Page 698, Figure 1 should be replaced by: Page 699, Results section, Left column, Second paragraph, “Of the patients who did not feel confident, more patients reported overdosing with Genuair, Ellipta, and Respimat (33.2%, 29.4%, and 21.4%, respectively).” should read “Of the patients who did not feel confident, more patients reported overdosing with Genuair, Ellipta, and Respimat (35.2%, 29.4%, and 21.4%, respectively).” Page 700, Discussion section, Right column, Fourth paragraph, “Limitations of the survey were that measures of patient adherence were based on patient report. Additionally, there may have been possible selection bias and recall bias. The survey was also not a randomized trial and reflected real-world experience.” should read “All possible efforts were made to ensure that the data received on Respimat were referring to tiotropium and not the use of short-acting bronchodilators; however this needs to be considered as a limitation of this analysis. Further limitations of the survey were that measures of patient adherence were based on patient report. Due to the nature of the trial, there might have been some recollection bias of some patients in specific countries, which indicated using the Respimat device longer than it had been approved. Additionally, there may have been possible selection bias and recall bias. The survey was also not a randomized trial and reflected real-world experience.” Page 701, Figure 4 should be replaced by:

          Related collections

          Author and article information

          Journal
          Int J Chron Obstruct Pulmon Dis
          Int J Chron Obstruct Pulmon Dis
          International Journal of COPD
          International Journal of Chronic Obstructive Pulmonary Disease
          Dove Medical Press
          1176-9106
          1178-2005
          2018
          25 July 2018
          25 July 2018
          : 13
          : 2253-2254
          Article
          copd-13-2253
          10.2147/COPD.S178410
          6065468
          © 2018 Price et al. This work is published and licensed by Dove Medical Press Limited

          The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

          Categories
          Erratum

          Respiratory medicine

          Comments

          Comment on this article